HPR76 Towards Market Access of Advanced Therapy Medicinal Products in the Netherlands: Reimbursement Pathways and Past Practices
Abstract
Authors
J Gort CC van Hattem G Frederix L Hooft LT Bloem R Ten Ham
J Gort CC van Hattem G Frederix L Hooft LT Bloem R Ten Ham
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now